1-Bromo-2-methoxy-3-nitrobenzene: Your Key Intermediate for Eltrombopag Synthesis

Discover the high-quality 1-Bromo-2-methoxy-3-nitrobenzene, a critical component manufactured in China for the synthesis of Eltrombopag. Ensure the purity and efficacy of your pharmaceutical products with our reliable supply.

Get a Quote & Sample

Advantages of Sourcing Our Intermediate

Consistent Quality for Eltrombopag

Our 1-Bromo-2-methoxy-3-nitrobenzene is produced under strict quality control, making it an ideal choice for pharmaceutical companies manufacturing Eltrombopag, a crucial drug for treating thrombocytopenia. Trust our manufacturer capabilities for your R&D and commercial needs.

Competitive Pricing & Availability

As a direct supplier in China, we offer competitive pricing for 1-Bromo-2-methoxy-3-nitrobenzene. Inquire about bulk purchase options and our ability to meet your production schedules, ensuring you can buy pharmaceutical intermediates at an advantageous price.

Expert Support for Your Synthesis

Leverage our expertise in chemical synthesis. We understand the importance of intermediates like CAS 98775-19-0 for complex API manufacturing. Partner with a knowledgeable supplier to facilitate your procurement process.

Key Applications and Markets

Eltrombopag Synthesis

The primary application of 1-Bromo-2-methoxy-3-nitrobenzene is as a key intermediate in the synthesis of Eltrombopag, a thrombopoietin receptor agonist used to treat low platelet counts.

Pharmaceutical API Manufacturing

This compound is crucial for manufacturers producing Active Pharmaceutical Ingredients (APIs), demanding high purity and reliable sourcing for their global markets.

Chemical R&D

Researchers and developers utilize this intermediate in various organic synthesis pathways, exploring new applications and improving existing chemical processes.

Global Pharmaceutical Supply Chain

We support the global pharmaceutical supply chain by providing essential building blocks like 1-Bromo-2-methoxy-3-nitrobenzene, ensuring seamless production for companies worldwide.